SCHEMBL4877501

SCHEMBL4877501

CCCCC1OCC(O)CO1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
SPHK2 Q9NRA0 6/20 0.39
SPHK1 Q9NYA1 6/20 0.39
EPHX1 P07099 1/20 0.39
PRKD3 O94806 2/20 0.38
PRKCG P05129 2/20 0.38
PRKCB P05771 2/20 0.38
PRKCA P17252 2/20 0.38
PRKCH P24723 2/20 0.38
PRKCI P41743 2/20 0.38
PRKCE Q02156 2/20 0.38
PRKCQ Q04759 2/20 0.38
PRKCZ Q05513 2/20 0.38
PRKCD Q05655 2/20 0.38
PRKD1 Q15139 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ENPP2 Q13822 1/20 0.36
LPAR2 Q9HBW0 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9413360 0.93 ALDH1A1 (0.56) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL13531582 0.91 ALDH1A1 (0.59) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL21518908 0.91 ALDH1A1 (0.59) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL25205855 0.91 ALDH1A1 (0.59) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL1681840 0.91 ALDH1A1 (0.59) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL25267185 0.91 ALDH1A1 (0.59) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL3792538 0.91 ALDH1A1 (0.59) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL4867685 0.86 ALDH1A1 (0.34) ALDH1A1SPHK2SPHK1EPHX1PRKD3
SCHEMBL25949 0.80
SCHEMBL27628067 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280997-A1 Novel Pharmaceutical or Cosmetic Carriers Containing Cyclic Acetals GATTEFOSSE SAS (FR) 2008-11-13 US disclosed
EP-1737495-A1 NOVEL PHARMACEUTICAL OR COSMETIC CARRIERS CONTAINING CYLCIC ACETALS GATTEFOSSE SAS (FR) 2007-01-03 EP disclosed
WO-2005105149-A1 NOVEL PHARMACEUTICAL OR COSMETIC CARRIERS CONTAINING CYLCIC ACETALS GATTEFOSSE SAS (FR) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280997-A1 Novel Pharmaceutical or Cosmetic Carriers Containing Cyclic Acetals ACAT2, ACACB, ACAT1 ALDH1A1 16/4885SPHK2 924/4885SPHK1 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.